MORGAN STANLEY PLC/CALL/MERCK & CO./165/0.1/19.09.25 Share Price

Warrant

DE000ME8HEB7

Real-time Bid/Ask 08:40:29 17/05/2024 pm IST
0.35 EUR / 0.36 EUR +1.43% Intraday chart for MORGAN STANLEY PLC/CALL/MERCK & CO./165/0.1/19.09.25
Current month-5.13%
1 month+2.78%
Date Price Change
17/24/17 0.34 -2.86%
16/24/16 0.37 +5.71%
15/24/15 0.35 +12.90%
14/24/14 0.31 0.00%
13/24/13 0.31 -11.43%

Delayed Quote Börse Stuttgart

Last update May 17, 2024 at 04:29 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN ME8HEB
ISINDE000ME8HEB7
Date issued 09/02/2024
Strike 165 $
Maturity 19/09/2025 (490 Days)
Parity 10 : 1
Emission price 0.33
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.52
Lowest since issue 0.28
Spread 0.01
Spread %2.86%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.9 USD
Average target price
141.6 USD
Spread / Average Target
+8.22%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW